Literature DB >> 22409531

Drug-induced alterations in Mg2+ homoeostasis.

Anke L Lameris1, Leo A Monnens, René J Bindels, Joost G J Hoenderop.   

Abstract

Magnesium (Mg2+) balance is tightly regulated by the concerted actions of the intestine, bone and kidneys. This balance can be disturbed by a broad variety of drugs. Diuretics, modulators of the EGFR (epidermal growth factor receptor), proton pump inhibitors, antimicrobials, calcineurin inhibitors and cytostatics may all cause hypomagnesaemia, potentially leading to tetany, seizures and cardiac arrhythmias. Conversely, high doses of Mg2+ salts, frequently administered as an antacid or a laxative, may lead to hypermagnesaemia causing various cardiovascular and neuromuscular abnormalities. A better understanding of the molecular mechanisms underlying the adverse effects of these medications on Mg2+ balance will indicate ways of prevention and treatment of these adverse effects and could potentially provide more insight into Mg2+ homoeostasis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22409531     DOI: 10.1042/CS20120045

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  18 in total

1.  Magnesium.

Authors:  Rebecca Costello; Taylor C Wallace; Andrea Rosanoff
Journal:  Adv Nutr       Date:  2016-01-15       Impact factor: 8.701

2.  Perspective: The Case for an Evidence-Based Reference Interval for Serum Magnesium: The Time Has Come.

Authors:  Rebecca B Costello; Ronald J Elin; Andrea Rosanoff; Taylor C Wallace; Fernando Guerrero-Romero; Adela Hruby; Pamela L Lutsey; Forrest H Nielsen; Martha Rodriguez-Moran; Yiqing Song; Linda V Van Horn
Journal:  Adv Nutr       Date:  2016-11-15       Impact factor: 8.701

Review 3.  Proton-pump inhibitor-induced hypomagnesemia: Current research and proposed mechanisms.

Authors:  Jeffrey H William; John Danziger
Journal:  World J Nephrol       Date:  2016-03-06

4.  [A 78-year-old female patient with dizziness, apraxia and seizure under proton pump inhibitor therapy].

Authors:  V Piezzi; G A Kullak-Ublick; P Glisenti
Journal:  Internist (Berl)       Date:  2014-02       Impact factor: 0.743

5.  P2X4 receptor regulation of transient receptor potential melastatin type 6 (TRPM6) Mg2+ channels.

Authors:  Jeroen H F de Baaij; Maxime G Blanchard; Marla Lavrijsen; Jens Leipziger; René J M Bindels; Joost G J Hoenderop
Journal:  Pflugers Arch       Date:  2014-01-12       Impact factor: 3.657

Review 6.  Evolving understanding of cardiovascular protection by SGLT2 inhibitors: focus on renal protection, myocardial effects, uric acid, and magnesium balance.

Authors:  Evan C Ray
Journal:  Curr Opin Pharmacol       Date:  2020-07-15       Impact factor: 5.547

7.  Alterations of Serum Magnesium Concentration in Animal Models of Seizures and Epilepsy-The Effects of Treatment with a GPR39 Agonist and Knockout of the Gpr39 Gene.

Authors:  Urszula Doboszewska; Jan Sawicki; Adam Sajnóg; Aleksandra Szopa; Anna Serefko; Katarzyna Socała; Mateusz Pieróg; Dorota Nieoczym; Katarzyna Mlyniec; Gabriel Nowak; Danuta Barałkiewicz; Ireneusz Sowa; Piotr Wlaź
Journal:  Cells       Date:  2022-06-21       Impact factor: 7.666

Review 8.  Renal control of calcium, phosphate, and magnesium homeostasis.

Authors:  Judith Blaine; Michel Chonchol; Moshe Levi
Journal:  Clin J Am Soc Nephrol       Date:  2014-10-06       Impact factor: 8.237

9.  Omeprazole enhances the colonic expression of the Mg(2+) transporter TRPM6.

Authors:  A L L Lameris; M W Hess; I van Kruijsbergen; J G J Hoenderop; R J M Bindels
Journal:  Pflugers Arch       Date:  2013-06-12       Impact factor: 3.657

10.  Intravenous infusion of magnesium chloride improves epicenter blood flow during the acute stage of contusive spinal cord injury in rats.

Authors:  Johongir M Muradov; Theo Hagg
Journal:  J Neurotrauma       Date:  2013-05-09       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.